Title: A Prospective Study of Clinical Profile of Patients Diagnosed with Malaria

Authors: Dr Dharmendra Singh, Dr Sanjay Dhawale, Dr Amit Garg

 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.123

Abstract

Background: Malaria is a major public health problem in India. Previous reports suggest that India reported 1.6 million cases and 1100 malaria deaths in the year 2015.

Aims and Objectives: To study the clinical profile of patients of malarial coming to a tertiary care hospital.

Materials and Methods: Hundred malaria patients were studied in the Department of Medicine, J.A. Group of Hospitals, GRMC Gwalior. Data on presenting complaints and general examination was performed. Complete haemogram, liver function test (serum bilirubin, SGOT, SGPT, ALP), bleeding time, clotting time was estimated.

Results: Maximum patients were in the age group of ≤30 years (56%) with equal distribution of gender. Majority had (19%) tachycardia, 9% had hypotension, 5% had tachypnea and 6% had hypoglycemia. Leucocytopenia was reported in 25% and leucocytosis in 2% patients. Majority (20%) had serum bilirubin of>2mg/dl, SGPT was increased in 35%, blood urea was increased in 7% and creatinine was increased in 6% malaria patients. Distribution of hepatomegaly and spleenomegaly was equally distributed among normal and abnormal SGPT and hemoglobin values.

Conclusion: Malaria was most common in working age group; fever, headache, nausea and vomiting were the most common symptoms. Pallor and icterus was the most common signs. An early diagnosis and treatment goes a long way in preventing avoidable deaths due to malaria.

Keywords: Leucocytopenia, protozoal disease, mortality, liver function test, organomegaly.

References

  1. Murray CJL, Lopez AD. Evidence based health policy- Lessons from the Global Burden of Disease Study. Science 1996;274:740-3.
  2. Aparup Das, Anupkumar R. Anvikara, Lauren J. Catorb, et al. Malaria in India: The Center for the Study of Complex Malaria in India. ActaTropica 2012; 121:267-73.
  3. Treatment of Malaria (Guidelines For Clinicians) Centers For Disease Control And Prevention treatment guidelines; 2013. http:// www.cdc.gov/malaria/resources/ pdf/clinicalguidance.pdf. Accessed 5 Apr 2019.
  4. Deshwal R. Vivax Malaria – Not Benign Anymore. JIACM 2011; 12:150-2.
  5. Sarvepalli AK, Dharana PK. Clinical profile, laboratory profile of malaria cases attending a tertiary care hospital in South India: twoyear study. Int J Adv Med 2017;4:540-5.
  6. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg 2007;77(6):69-78.
  7. Clinical profile of falciparum malaria with special reference to complications and outcome. RGUHS 2010;22:23-9.
  8. Echeverri M, Álvarez GT, Carmona J, Blair S. Clinical and laboratory findings of Plasmodium vivax malaria in Colombia, 2001. Rev Inst Med Trop S Paulo 2003; 45:29-34.
  9. Tangpukdee N, Thanachartwet V, Krudsood S, Luplertlop N, Pornpininworakij, K, Chalermrut K et al. Minor liver profile dysfunctions in Plasmodium vivax, P. malariae and P. ovale patients and normalization after treatment. Korean Journal of Parasitology 2006; 4:295-302.
  10. Harris VK, Richard VS, Mathai E, Sitaram U, Kumar VK, Cherian AM et al. Study of clinical profile of falciparum malaria in tertiary care hospital in south India. Indian J Malariol 2001;38:19-24
  11. Rasheed A, Saeed S, Khan SA. Clinical and laboratory findings in acute malaria caused by various plasmodium species. J Pak Med Assoc 2009; 59:220-23.
  12. Deshwal R. Clinical and Laboratory Profile of Hospitalized Malarial Patients: An Agra-Based Study. Journal of The Association of Physicians of India 2016;64:44-7.

Corresponding Author

Dr Sanjay Dhawale

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mob: 9329806580